Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Covering weight-loss drugs for elderly Americans on the state-backed Medicare health insurance programme would cost the US government $35bn over the next nine years, a congressional analysis has found ...

A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

Some Rice University researchers have partnered with other institutions to continue bioelectrical implant treatment ...

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins. NHS England ...

WeightWatchers said it will market the medication as part of its comprehensive ... Zepbound weight loss medications that are used to treat obesity have proven to be extremely popular, resulting ...

In an interview with Al Jarida, Dr. Reda noted that discontinuing medication often results in regaining weight ... Dr. Reda further explained that the decision to prescribe obesity medications follows ...

The report shows a rise in medication use, obesity, and smoking, a decline in cancer screenings, concerns over excessive sleep, and anti-anxiety drug consumption. A woman undergoes a free ...